Antimicrobial Agents Practice Questions

Q: Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Vancomycin. ### Explanation **Correct Option: C. Vancomycin** Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan precursor (muramyl pentapeptide). This binding creates a "steric hindrance" that prevents the **transglycosylase** enzyme from adding new subunits to the growing peptidoglycan chain. By interfering with the addition of these subunits, it halts the elongation of the cell wall. **Analysis of Incorrect Options:** * **A. Bacitracin:** Inhibits cell wall synthesis by interfering with the **dephosphorylation of the lipid carrier (bactoprenol)**, which transports peptidoglycan subunits across the cell membrane. It does not bind to the subunits themselves. * **B. Penicillins:** These are Beta-lactams that inhibit the **transpeptidase** enzyme (Penicillin Binding Proteins). They prevent the **cross-linking** of peptidoglycan chains rather than the addition of new subunits. * **C. Mupirocin:** This is a protein synthesis inhibitor. It acts by binding to bacterial **isoleucyl-tRNA synthetase**, preventing the incorporation of isoleucine into nascent proteins. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** The most common mechanism for Vancomycin resistance (e.g., VRSA/VRE) is the alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**. * **Red Man Syndrome:** A common infusion-related reaction caused by direct histamine release (not a true IgE-mediated allergy). It is managed by slowing the infusion rate. * **Spectrum:** Vancomycin is active only against **Gram-positive** bacteria (it is too large to pass through the porins of Gram-negative outer membranes). * **Drug of Choice:** It remains the gold standard for **MRSA** (Methicillin-resistant *Staphylococcus aureus*).

Q: Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Nelfinavir. **Explanation:** The concept of **"Ritonavir Boosting"** relies on the ability of Ritonavir to act as a potent inhibitor of the **CYP3A4 enzyme**. By inhibiting this enzyme, Ritonavir slows the metabolism of co-administered Protease Inhibitors (PIs), leading to higher plasma concentrations, a longer half-life, and reduced dosing frequency. **Why Nelfinavir is the Correct Answer:** Nelfinavir is the only Protease Inhibitor that is **not** boosted by Ritonavir. Unlike other PIs, Nelfinavir is primarily metabolized by **CYP2C19** (and to a lesser extent by CYP3A4 and CYP2C9). Furthermore, Nelfinavir’s active metabolite (M8) is also potent. Because its primary metabolic pathway is not CYP3A4-dependent, adding Ritonavir does not significantly increase its plasma levels to a clinically beneficial degree. **Analysis of Incorrect Options:** * **Darunavir & Lopinavir:** These are "second-generation" PIs that are almost always administered with Ritonavir. In fact, Lopinavir is only available as a fixed-dose combination with Ritonavir (Kaletra) because its bioavailability is too poor otherwise. * **Saquinavir:** This was the first PI developed. It has very low oral bioavailability, which is significantly improved (boosted) when combined with Ritonavir. **High-Yield Clinical Pearls for NEET-PG:** * **Lopinavir/Ritonavir:** The "Gold Standard" for boosted PI therapy, often used in second-line ART regimens. * **Adverse Effects:** PIs are classically associated with **Lipodystrophy** (buffalo hump), **Hyperlipidemia**, and **Insulin Resistance**. * **Nelfinavir Specifics:** It is frequently associated with **diarrhea** as a major side effect. * **Atazanavir:** Another PI that requires boosting; it is unique for causing unconjugated hyperbilirubinemia (benign jaundice).

Q: All the following antiretroviral drugs produce dyslipidemia except?

Atazanavir. ### Explanation **Core Concept:** Protease Inhibitors (PIs) are a class of antiretroviral drugs notorious for causing metabolic complications, including **dyslipidemia** (hypertriglyceridemia and hypercholesterolemia), insulin resistance, and lipodystrophy (buffalo hump/central obesity). This occurs because PIs inhibit the breakdown of lipids by interfering with proteins like LRP (low-density lipoprotein receptor-related protein) and CRABP-1. **Why Atazanavir is the Correct Answer:** **Atazanavir** is unique among the older Protease Inhibitors because it is **metabolically neutral**. It does not significantly alter lipid profiles or cause insulin resistance. Therefore, it is the preferred PI for patients with pre-existing cardiovascular risk factors or dyslipidemia. **Analysis of Incorrect Options:** * **B, C, and D (Saquinavir, Amprenavir, Nelfinavir):** These are "first-generation" or traditional Protease Inhibitors. They are strongly associated with significant elevations in LDL and triglycerides. Nelfinavir and Ritonavir are often cited as having the highest risk of metabolic derangements. **High-Yield Clinical Pearls for NEET-PG:** * **Atazanavir Side Effect:** While it spares lipids, it frequently causes **unconjugated hyperbilirubinemia** (jaundice) due to UGT1A1 inhibition, similar to Gilbert’s syndrome. * **Lipodystrophy:** Characterized by "Crix-belly" (named after Crixivan/Indinavir) and peripheral fat wasting. * **Drug Interactions:** PIs are potent **CYP3A4 inhibitors** (especially Ritonavir, used as a "booster"). * **Darunavir:** Currently the most commonly used PI; it has a better lipid profile than Nelfinavir but is not as "lipid-neutral" as Atazanavir.

Q: What is the drug of choice for Falciparum Malaria?

Artemisinin-based Combination Therapy (ACT). **Explanation:** The management of malaria is a high-yield topic for NEET-PG, focusing on drug resistance patterns and current WHO/National guidelines. **Why ACT is the Correct Answer:** **Artemisinin-based Combination Therapy (ACT)** is currently the global drug of choice for **uncomplicated *Plasmodium falciparum* malaria**. The rationale behind using a combination (e.g., Artesunate + Sulfadoxine-Pyrimethamine or Artemether + Lumefantrine) is twofold: 1. **Rapid Clearance:** Artemisinins are the fastest-acting schizontocides, reducing the parasite biomass rapidly. 2. **Resistance Prevention:** The longer-acting partner drug eliminates residual parasites, preventing the development of resistance to artemisinin. **Analysis of Incorrect Options:** * **A. Chloroquine:** While it remains the drug of choice for *P. vivax*, it is no longer used for *P. falciparum* due to widespread **high-level resistance** (mutations in the *pfcrt* gene). * **B. Mefloquine:** Used primarily for prophylaxis in travelers or as a component of certain ACTs (Artesunate + Mefloquine), but it is not the first-line monotherapy due to neuropsychiatric side effects. * **D. Proguanil:** Usually used in combination with Atovaquone (Malarone) for prophylaxis or treatment in specific regions, but it is not the standard first-line recommendation for *falciparum* in endemic areas like India. **Clinical Pearls for NEET-PG:** * **Severe/Complicated Malaria:** The drug of choice is **Intravenous (IV) Artesunate**. * **Pregnancy:** ACT is now recommended for *falciparum* malaria in **all trimesters** (including the first). * **Gametes:** Artemisinins have gametocytocidal action against *P. falciparum*, helping reduce transmission. * **India Specific:** In India, the preferred ACT is **Artesunate + Sulfadoxine-Pyrimethamine (AS+SP)**, except in North-Eastern states where **Artemether + Lumefantrine** is used due to SP resistance.

Q: Which of the following drugs can cause acute pancreatitis?

Didanosine. **Didanosine (ddI)**, a Nucleoside Reverse Transcriptase Inhibitor (NRTI), is classically associated with **acute pancreatitis** as its most significant dose-limiting toxicity [1]. The underlying mechanism involves mitochondrial toxicity; NRTIs can inhibit mitochondrial DNA polymerase-gamma, leading to mitochondrial dysfunction in pancreatic acinar cells [2]. This risk is significantly increased when combined with Stavudine or in patients with pre-existing alcoholism or hypertriglyceridemia [1]. **Analysis of Incorrect Options:** * **Abacavir (A):** The hallmark adverse effect is a potentially fatal **Hypersensitivity Reaction** (HSR), strongly linked to the **HLA-B*5701** allele. It is not typically associated with pancreatitis [1]. * **Lamivudine (B):** Generally considered the least toxic NRTI. While it can rarely cause pancreatitis in pediatric patients, it is not the primary association compared to Didanosine. * **Zidovudine (C):** The primary dose-limiting toxicities are **bone marrow suppression** (anemia and neutropenia) and myopathy. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Didanosine (ddI):** "P" for **P**ancreatitis and **P**eripheral neuropathy. * **Stavudine (d4T):** Also causes peripheral neuropathy and has the highest risk of **Lipoatrophy** (fat loss from face/limbs) and lactic acidosis. * **Zidovudine (AZT):** Used for the prevention of vertical transmission (mother-to-child) of HIV. * **Tenofovir:** An N**t**RTI (Nucleo**t**ide) associated with renal toxicity (Fanconi syndrome) and bone density loss.

Q: Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Proguanil. **Explanation:** Anti-malarial drugs are classified based on the stage of the *Plasmodium* life cycle they target. The **pre-erythrocytic (exo-erythrocytic) phase** occurs in the liver immediately after a mosquito bite, before the parasites enter the bloodstream. **1. Why Proguanil is Correct:** Proguanil (and its active metabolite cycloguanil) acts as a **causal prophylactic** agent. It inhibits the enzyme dihydrofolate reductase (DHFR), disrupting DNA synthesis in the primary liver stages of both *P. falciparum* and *P. vivax*. This prevents the infection from ever reaching the red blood cells. It is often used in combination with Atovaquone (Malarone) for this purpose. **2. Why the Incorrect Options are Wrong:** * **Chloroquine:** It is a potent **blood schizonticide**. It acts by inhibiting heme polymerase in the erythrocytic stage but has no activity against liver stages. * **Pyrimethamine:** While it also inhibits DHFR, it is primarily effective against the erythrocytic stages and is used as a **slow-acting blood schizonticide** (usually combined with Sulfadoxine). It is not typically used for causal prophylaxis. * **Quinine:** An alkaloid that acts as a rapid **blood schizonticide**. It is used for severe malaria but lacks activity against any hepatic stages. **High-Yield NEET-PG Pearls:** * **Causal Prophylactics (Liver stage):** Proguanil, Primaquine, and Pyrimethamine (weakly). * **Radical Cure (Hypnozoites):** Primaquine and Tafenoquine are the only drugs that kill dormant liver stages (*P. vivax/ovale*). * **Drug of Choice for Pregnancy:** Chloroquine (if sensitive); Quinine is safe for severe malaria in all trimesters. * **Proguanil Side Effect:** Mouth ulcers (stomatitis) are a characteristic adverse effect.

Q: Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Penicillins and Cephalosporins. ### Explanation **1. Why Penicillins and Cephalosporins are Correct:** In pregnancy, drug safety is categorized based on the potential risk to the fetus. **Penicillins** (e.g., Amoxicillin, Ampicillin) and **Cephalosporins** (e.g., Cephalexin, Ceftriaxone) are considered **Category B** drugs. They are the first-line agents for treating Urinary Tract Infections (UTIs) because they lack teratogenic potential and have a high therapeutic index. Their mechanism of action—inhibiting bacterial cell wall synthesis—targets a process absent in human cells, making them exceptionally safe for both the mother and the developing fetus. **2. Why Other Options are Incorrect:** * **Aminoglycosides (Options A & B):** These are contraindicated (Category D) as they can cause **fetal ototoxicity** (damage to the 8th cranial nerve) and potential nephrotoxicity. * **Fluoroquinolones/Ciprofloxacin (Options B & D):** These are avoided in pregnancy because they have a high affinity for bone and cartilage, potentially leading to **arthropathy** and permanent cartilage damage in the fetus. * **Cotrimoxazole (Option D):** This is a combination of Sulfonamides and Trimethoprim. Trimethoprim is a **folate antagonist** (risk of neural tube defects in the 1st trimester), and Sulfonamides can displace bilirubin from albumin, leading to **kernicterus** in the newborn if used near term. **3. NEET-PG High-Yield Pearls:** * **Nitrofurantoin:** Safe in the 2nd trimester but contraindicated at term (38-42 weeks) due to the risk of **hemolytic anemia** in the newborn (due to immature G6PD enzymes). * **Fosfomycin:** A single-dose safe alternative for uncomplicated cystitis in pregnancy. * **Asymptomatic Bacteriuria:** In pregnancy, this **must** always be treated to prevent progression to pyelonephritis and preterm labor.

Q: What is the drug of choice for dysentery caused by Shigella?

Ciprofloxacin. **Shigellosis (Bacillary Dysentery)** is characterized by high-grade fever, abdominal cramps, and frequent small-volume stools containing blood and mucus. The primary goal of treatment is to reduce the duration of illness and prevent person-to-person transmission. **Why Ciprofloxacin is the Correct Answer:** Fluoroquinolones, specifically **Ciprofloxacin**, are currently the **drug of choice (DOC)** for Shigella dysentery in both adults and children, as recommended by the WHO. They are highly effective because they achieve high concentrations in the intestinal mucosa and are bactericidal against most *Shigella* species. In cases of resistance, Ceftriaxone or Azithromycin are used as alternatives. **Analysis of Incorrect Options:** * **A & C (Doxycycline/Tetracycline):** While tetracyclines were used historically, widespread plasmid-mediated resistance has rendered them ineffective against most *Shigella* strains globally. * **D (No antibiotic recommended):** Unlike *Salmonella* gastroenteritis (where antibiotics may prolong the carrier state), *Shigella* is an invasive pathogen. Antibiotics are **strongly recommended** for all cases of suspected shigellosis to limit the clinical course and reduce the risk of complications like HUS (Hemolytic Uremic Syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Ciprofloxacin inhibits **DNA Gyrase (Topoisomerase II)** and Topoisomerase IV, preventing bacterial DNA replication [1]. * **Pediatric Note:** Although fluoroquinolones are generally avoided in children due to potential cartilage damage, they are the **DOC for pediatric shigellosis** because the benefits outweigh the risks. * **Avoid Antimotility Agents:** Loperamide is **contraindicated** in Shigella dysentery as it can worsen the infection and increase the risk of toxic megacolon.

Question 1

A bedridden female patient has a catheter-related urinary tract infection caused by beta-lactamase producing Klebsiella pneumoniae. Which of the following drugs would you choose?

Accepted Answer

Beta-lactam and beta-lactamase inhibitors

Answer

Ampicillin

Answer

2nd generation cephalosporins

Answer

3rd generation cephalosporins

Question 2

Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Accepted Answer

Vancomycin

Answer

Bacitracin

Answer

Penicillins

Answer

Mupirocin

Question 3

Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Accepted Answer

Nelfinavir

Answer

Darunavir

Answer

Saquinavir

Answer

Lopinavir

Question 4

All the following antiretroviral drugs produce dyslipidemia except?

Accepted Answer

Atazanavir

Answer

Saquinavir

Answer

Amprenavir

Answer

Nelfinavir

Question 5

What is the drug of choice for Falciparum Malaria?

Accepted Answer

Artemisinin-based Combination Therapy (ACT)

Answer

Chloroquine

Answer

Mefloquine

Answer

Proguanil

Question 6

Which of the following drugs can cause acute pancreatitis?

Accepted Answer

Didanosine

Answer

Abacavir

Answer

Lamivudine

Answer

Zidovudine

Question 7

Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Accepted Answer

Proguanil

Answer

Chloroquine

Answer

Pyrimethamine

Answer

Quinine

Question 8

Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Accepted Answer

Penicillins and Cephalosporins

Answer

Aminoglycosides and Penicillins

Answer

Aminoglycosides and Ciprofloxacin

Answer

Cotrimoxazole and Ciprofloxacin

Question 9

What is the drug of choice for dysentery caused by Shigella?

Accepted Answer

Ciprofloxacin

Answer

Doxycycline

Answer

Tetracycline

Answer

No antibiotic is recommended

Question 10

Interferons are indicated in chronic hepatitis B in which of the following situations?

Accepted Answer

Active HBV replication

Answer

Early onset

Answer

Normal ALT levels

Answer

All the above

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?